SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-18-027395
Filing Date
2018-04-27
Accepted
2018-04-27 08:38:12
Documents
3
Effectiveness Date
2018-04-27

Document Format Files

Seq Description Document Type Size
1 DEFA14A a18-3067_3defa14a.htm DEFA14A 31860
2 GRAPHIC g30673bci001.jpg GRAPHIC 167931
3 GRAPHIC g30673bci002.jpg GRAPHIC 141271
  Complete submission text file 0001104659-18-027395.txt   458933
Mailing Address 863 MITTEN ROAD SUITE 102 BURLINGAME CA 94010
Business Address 863 MITTEN ROAD SUITE 102 BURLINGAME CA 94010 (650) 900-4520
Corvus Pharmaceuticals, Inc. (Filer) CIK: 0001626971 (see all company filings)

IRS No.: 464670809 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37719 | Film No.: 18781147
SIC: 2834 Pharmaceutical Preparations